Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study

BACKGROUND: Log odds of positive lymph nodes (LODDS) is a novel lymph node (LN) descriptor that demonstrates promising prognostic value in many tumors. However, there is limited information regarding LODDS in patients with non-small cell lung cancer (NSCLC), especially those receiving neoadjuvant th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qing, Wang, Suyu, Sun, Zhiyong, Cao, Min, Zhao, Xiaojing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297565/
https://www.ncbi.nlm.nih.gov/pubmed/35858848
http://dx.doi.org/10.1186/s12885-022-09908-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297565/
https://www.ncbi.nlm.nih.gov/pubmed/35858848
http://dx.doi.org/10.1186/s12885-022-09908-3

Ejemplares similares